Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells-Reference-Cited by-同舟云学术

Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells

Published:2003-06-03 Issue:1 Volume:106 Page:108-115
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Miao Ze-Hong,Tang Tao,Zhang Yi-Xiang,Zhang Jin-Sheng,Ding Jian

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference47 articles.

1. Resistance to cytotoxic agents

2. Multidrug resistance in cancer: role of ATP–dependent transporters

3. Inhibitors of Multidrug Resistance to Antitumor Agents (MDR)

4. Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Therapeutic Potentiality of Natural Products in Cancer Therapy: A Recent Update and Current Prospects;Current Cancer Therapy Reviews;2025-01

2. Enhanced delivery of doxorubicin for breast cancer treatment using pH-sensitive starch/PVA/g-C3N4 hydrogel;International Journal of Biological Macromolecules;2024-04

3. Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery;RSC Advances;2024

4. Reconciling the Gap between Medications and their Potential Leads: The Role of Marine Metabolites in the Discovery of New Anticancer Drugs: A Comprehensive Review;Current Pharmaceutical Design;2023-11

5. Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients;Egyptian Journal of Medical Human Genetics;2023-01-03